In Brief: Guidant
This article was originally published in The Gray Sheet
Executive Summary
Guidant: Commences clinical trial of its coronary intravascular radiotherapy system for reduction of restenosis following interventional cardiology procedures Oct. 28 at the Methodist Hospital of Baylor College in Houston, Texas. Guidant received investigational device exemption approval in September to begin the PREVENT trial (Proliferation Reduction with Vascular Energy Trial), which will also take place at the Thoraxcentre in Rotterdam, The Netherlands and the Northern General Hospital in Sheffield, U.K. The radiotherapy system consists of a flexible source wire with a radioactive isotope in its tip, a source delivery unit and a centering catheter, through which the source wire is placed...